ETFs positioned on Amgen Inc.

Name YTD change Weight AuM
+14.04%-.--% 35,761 M€
+11.19%-.--% 27,154 M€
+6.44%-.--% 49 M€
+9.30%-.--% 66 M€
+7.14%-.--% 67 M€
0.00%-.--% 67 M€
+7.11%-.--% 75 M€
+10.66%-.--% 122 M€
+3.28%-.--% 165 M€
-1.34%-.--% 33 M€
+14.60%-.--% 669 M€
+10.28%-.--% 1,251 M€
+19.79%-.--% 1,646 M€
+13.38%-.--% 1,674 M€
+15.65%-.--% 2,210 M€
+13.75%-.--% 2,303 M€
+9.73%-.--% 12,921 M€
+23.71%17.04% 429 M€
+22.84%8.97% 1,079 M€
+22.37%8.97% 78 M€
+21.21%8.81% 9,953 M€
+22.16%7.76% 81 M€
+12.18%7.16% 503 M€
+0.58%6.85% 5 M€
+15.53%5.86% 379 M€
+6.74%5.41% 7 M€
0.00%4.96% 5 M€
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!